FRIDAY, Sept. 29, 2023 (HealthDay News) – Despite reports of trouble last week where some people may have been denied insurance coverage while seeking COVID shots at pharmacies, the Biden administration said Thursday those issues have been ironed out.
That issue is "largely, if not completely," resolved after U.S. Health and Human Services Secretary Secretary
FRIDAY, Sept. 29, 2023 (HealthDay News) – When pregnant women get a COVID vaccine, it helps protect their newborns from the virus, a new government study shows.
"These findings indicate that maternal vaccination during pregnancy could help prevent COVID-19–related hospitalization in infants too young to be vaccinated," researchers from the U.S. Centers for Disease Co...
Just 23% of American adults say they 'definitely' will get the new COVID-19 vaccine, while another 23% say they will 'probably' get it, according to a new poll, which also finds interest in the shot falls along partisan lines.
More people plan to get seasonal flu shots and the new vaccine to help prevent severe symptoms for respiratory syncytial virus or RSV.
Women may soon have a vaccine they can take during a pregnancy to help protect their newborn from respiratory syncytial virus (RSV).
Following approval one month ago by the U.S. Food and Drug Administration, the Centers for Disease Control and Prevention on Friday also approved the shot, called Abrysvo. That marks the last hurdle needed for the vaccine to become widely available.
An oral vaccine for COVID-19 appears to produce the sort of immune response that could quickly stamp out a developing infection, according to results from a small-scale primate study.
Some monkeys given an experimental COVID vaccine tablet under their tongue developed the type of antibodies that might block the coronavirus as it attempts to infect the body through the mucous membranes of ...
Following on an approval granted Monday by the U.S. Food and Drug Administration, an expert panel from the U.S. Centers for Disease Control and Prevention on Tuesday also signed off on new COVID boosters for Americans.
Final approval is expected from CDC Director Dr. Mandy Cohen, which would set the stage for the updated vaccines to soon become available.
The U.S. Food and Drug Administration on Monday gave the green light to new COVID boosters for Americans, setting the stage for the updated vaccines to become available within days.
The COVID-19 shots from Pfizer and Moderna will join the flu shot and newly approved RSV shots as part of a three-pronged public health strategy to tame the spread of all three viruses this coming winter. The ...
MONDAY, Sept. 11, 2023 (HealthDay News) – In a finding that should ease the minds of Americans ahead of another flu season, this year's vaccines have already cut the risk of hospitalization in half during the South American winter, health officials report.
Even better, the flu virus strains that have been detected in the United States have so far shown a similar pattern to those in Sout...
Some good news for folks who are worried about the new, troublesome COVID variant known as BA.2.86: Moderna Inc. said Wednesday that its updated vaccine held its own against this highly mutated version of the virus.
While approval for the newest version of the vaccine is still pending from the U.S. Food and Drug Administration, the company offered good reason for why the agency should gi...
Women may soon have a vaccine they can take during a pregnancy to help protect their newborn from respiratory syncytial virus (RSV), following U.S. Food and Drug Administration approval of the shot, called Abrysvo, on Monday
The vaccine is designed to be given to pregnant women between 32 and 36 weeks of pregnancy as a way to protect infants from birth through 6 months from the sometimes ...
Certain adult vaccines, including shingles and pneumonia shots, may also help seniors fight off Alzheimer's disease, new research reveals.
Prior vaccination with the shingles vaccine, pneumococcus vaccine or the tetanus and diphtheria shot, with or without an added pertussis vaccine, are associated with a 25% to 30% reduced risk of Alzheimer’s disease, according to researchers from...
People may assume that a COVID-19 infection protects them the next time they encounter the virus, but that’s not necessarily true.
A new study of 750 vaccinated seniors living in retirement homes and long-term care facilities found that those infected during the first omicron wave were actually more vulnerable to reinfection with a later wave.
As experts begin preparing for another season of viruses, they now know that even healthy infants with no underlying health issues are at risk for severe respiratory syncytial virus (RSV).
New research finds that most infants who were admitted last fall to an intensive care unit for RSV were generally healthy before their infection. So, preventative measures -- including a newly approved ...
A variant nicknamed Eris now accounts for the largest proportion of new COVID infections across America.
About 17.3% of U.S. COVID cases are believed to have been caused by the variant, formally known as EG.5, in early August, according to the U.S. Centers for Disease Control and Prevention. That number is 7.5% higher than it was in early July.
While both the Moderna and Pfizer COVID-19 vaccines are considered safe and highly effective, new research finds the Moderna shot has been the safest and most effective for seniors.
“The results of this study can help public health experts weigh which mRNA vaccine might be preferred for older adults and older subgroups, such as those with increased frailty,” said lead study author
Most early childhood vaccines require three or four doses for best protection, but more than 1 in 6 toddlers aren't getting them all, leaving them vulnerable to potentially deadly infections, a new study finds.
There are many reasons that kids aren't completing their vaccine series, according to researchers. Some families may have moved across state lines and others may lack health insura...
MONDAY, July 17, 2023 (HealthDay Now) -- Parents now have a new long-acting drug to protect their children against respiratory syncytial virus (RSV), a common germ that hospitalizes as many as 3% of children under the age of 1 in the United States each year.
Americans ages 60 and up can get their vaccine for respiratory syncytial virus (RSV) this fall, the U.S. Centers for Disease Control and Prevention announced Thursday.
On Thursday, Dr. Rochelle Walensky, the outgoing CDC director, gave her signature to a recommendation made last week by an advisory panel of outside experts for a single dose of the vaccines made by Pfizer and GSK. The FDA ...
An advisory panel to the U.S. Food and Drug Administration voted unanimously on Thursday to recommend that COVID booster shots be updated for the fall to protect solely against one of the three XBB variants that have taken hold in the United States.
Those three XBB variants, which are all sublineages of the Omicron variant, are XBB.1.5, XBB.1.16 and XBB.2.3, CNN reported. What wi...
COVID-19 boosters may be offered this fall, but first scientists need to determine what strains to target and who should receive the shots.
Advisers to the U.S. Food and Drug Administration are slated to meet Thursday to discuss plans for fall, a decision with a deadline because drugmakers will need to have the time to manufacture the shots, NBC News reported.
A U.S. Food and Drug Administration advisory panel on Thursday recommended that the agency approve an RSV vaccine for infants and some toddlers.
The monoclonal antibody shot would protect against respiratory syncytial virus (RSV) in infants born during or entering their first RSV season, the New York Times reported. It could also be used for toddlers up to 24 months old who are p...
People unvaccinated for COVID-19 have significant odds of lingering illness if they get the virus, with one in six still suffering symptoms two years later, new research shows.
A study from Switzerland found that 17% of that group did not return to their previously normal health, and 18% reported COVID symptoms such as shortness of breath 24 months after their infection was gone.
It was a no-brainer for New York City mom Jen L. when a pediatrician suggested that she vaccinate her two sons against human papillomavirus (HPV).
“Before my kids were eligible for the vaccine, I had read up on it to learn about the vaccine and its positives in general, and also to learn if there were any significant side effects," she said. “I have a good friend who had issues f...
The first vaccine designed to protect infants against respiratory syncytial virus (RSV) by vaccinating their mothers during pregnancy has been backed by a panel of advisers to the U.S. Food and Drug Administration.
On Thursday the independent committee of experts voted unanimously that the Pfizer-made vaccine was effective, and 10-4 that there was adequate data on safety to move the vacci...
Severely obese people may need more frequent COVID-19 booster shots to keep their immunity going, new research suggests.
Protection from the shots declines more rapidly in those who are severely obese compared to those at a normal weight, according to scientists at the Universities of Cambridge and Edinburgh in the United Kingdom.
"Because of the high prevalence of obesity across ...